Clinical Trials Browser

Phase 1 × Behavior Therapy × Tumor-Agnostic × Clear all

NCT06644170 2025-10-14

A Second Psilocybin Group Therapy for the Treatment of Cancer-Related Anxiety in Partial Responders With Metastatic Cancer

Phase 1 Completed

Neoplasm Metastasis